ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,627.10
      1.27%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. TCR2 Therapeutics Inc (TCRR)

      7. TCR2 Therapeutics Inc (TCRR) News

      TCRR

      TCR2 Therapeutics (TCRR)

      TCR2 Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TCRR
      DateTimeSourceHeadlineSymbolCompany
      05/22/20237:33AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/22/20237:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/11/20237:17AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/11/20237:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/11/20236:30AMGlobeNewswire Inc.TCR² Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TCRRTCR2 Therapeutics Inc
      05/08/20234:05PMGlobeNewswire Inc.TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/05/20236:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/05/20236:50PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TCRRTCR2 Therapeutics Inc
      05/05/20234:38PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCRRTCR2 Therapeutics Inc
      04/20/20234:51PMEdgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:TCRRTCR2 Therapeutics Inc
      04/03/20234:15PMGlobeNewswire Inc.TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/23/20237:52AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/23/20237:17AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/23/20237:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/23/20236:30AMGlobeNewswire Inc.TCR² Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:TCRRTCR2 Therapeutics Inc
      03/10/20234:51PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/09/20234:18PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/06/20234:32PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/06/20234:28PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/06/20234:28PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TCRRTCR2 Therapeutics Inc
      03/06/20236:00AMGlobeNewswire Inc.Adaptimmune and TCR² Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid TumorsNASDAQ:TCRRTCR2 Therapeutics Inc
      02/14/20234:02PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCRRTCR2 Therapeutics Inc
      02/09/20236:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCRRTCR2 Therapeutics Inc
      02/08/20236:45AMGlobeNewswire Inc.TCR² Therapeutics to Present at SVB Securities Global Biopharma Conference 2023NASDAQ:TCRRTCR2 Therapeutics Inc
      01/05/20234:15PMGlobeNewswire Inc.TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TCRRTCR2 Therapeutics Inc
      01/05/20239:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRRTCR2 Therapeutics Inc
      01/05/20238:45AMGlobeNewswire Inc.TCR² Therapeutics Announces Pipeline Priorities for 2023NASDAQ:TCRRTCR2 Therapeutics Inc
      12/19/20225:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      12/19/20225:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
      12/19/20225:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRRTCR2 Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:TCRR